CIK: 0002052213 · Show all filings
Period: Q4 2025
Filing Date: Feb 17, 2026
Total Value ($000): $338,852 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| COGT | COGENT BIOSCIENCES INC | 1,170,740 | $41,585 | 12.3% | $28.11 | 0.0% | COM | 19240Q201 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 1,855,000 | $38,974 | 11.5% | $17.45 | 0.0% | COM | 87164F105 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 858,631 | $26,721 | 7.9% | $27.43 | 0.0% | COM | 92790C104 |
| VERA | VERA THERAPEUTICS INC | 482,500 | $24,434 | 7.2% | $35.52 | 0.0% | CL A | 92337R101 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 865,000 | $23,493 | 6.9% | $26.34 | 0.0% | COM NEW | 15117B202 |
| CGON | CG ONCOLOGY INC | 492,500 | $20,449 | 6.0% | $41.38 | 0.0% | COM | 156944100 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 2,150,000 | $16,770 | 4.9% | $7.23 | 0.0% | COM | 09058V103 |
| PCVX | VAXCYTE INC | 291,500 | $13,450 | 4.0% | $44.73 | 0.0% | COM | 92243G108 |
| BEAM | BEAM THERAPEUTICS INC | 476,338 | $13,204 | 3.9% | $25.51 | 0.0% | COM | 07373V105 |
| PHVS | PHARVARIS N V | 475,750 | $13,202 | 3.9% | $24.09 | 0.0% | COM | N69605108 |
| KALV | KALVISTA PHARMACEUTICALS INC | 801,300 | $12,941 | 3.8% | $13.24 | 0.0% | COM | 483497103 |
| — | DYNAVAX TECHNOLOGIES CORP | 679,900 | $10,457 | 3.1% | $15.38 | — | COM NEW | 268158201 |
| TYRA | TYRA BIOSCIENCES INC | 350,000 | $9,202 | 2.7% | $18.37 | 0.0% | COM | 90240B106 |
| NRIX | NURIX THERAPEUTICS INC | 460,000 | $8,726 | 2.6% | $14.37 | 0.0% | COM | 67080M103 |
| WVE | WAVE LIFE SCIENCES LTD | 447,846 | $7,613 | 2.2% | $10.16 | 0.0% | SHS | Y95308105 |
| MBX | MBX BIOSCIENCES INC | 211,000 | $6,655 | 2.0% | $24.26 | 0.0% | COM | 55287L101 |
| KRYS | KRYSTAL BIOTECH INC | 22,000 | $5,424 | 1.6% | $210.47 | 0.0% | COM | 501147102 |
| UTHR | UNITED THERAPEUTICS CORP DEL | 11,000 | $5,360 | 1.6% | $465.69 | 0.0% | COM | 91307C102 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 82,000 | $4,873 | 1.4% | $54.44 | 0.0% | COM | 09061G101 |
| RLAY | RELAY THERAPEUTICS INC | 536,946 | $4,543 | 1.3% | $7.14 | 0.0% | COM | 75943R102 |
| TVTX | TRAVERE THERAPEUTICS INC | 110,000 | $4,203 | 1.2% | $32.52 | 0.0% | COM | 89422G107 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 38,000 | $3,319 | 1.0% | $81.85 | 0.0% | COM | 74366E102 |
| CGEM | CULLINAN THERAPEUTICS INC | 310,000 | $3,209 | 0.9% | $9.02 | 0.0% | COM | 230031106 |
| LQDA | LIQUIDIA CORPORATION | 90,000 | $3,104 | 0.9% | $28.47 | 0.0% | COM NEW | 53635D202 |
| CTMX | CYTOMX THERAPEUTICS INC | 700,000 | $2,982 | 0.9% | $3.80 | 0.0% | COM | 23284F105 |
| URGN | UROGEN PHARMA LTD | 100,000 | $2,342 | 0.7% | $21.69 | 0.0% | COM | M96088105 |
| IMCR | IMMUNOCORE HLDGS PLC | 58,248 | $2,022 | 0.6% | $34.71 | — | ADS | 45258D105 |
| DSGN | DESIGN THERAPEUTICS INC | 207,900 | $1,950 | 0.6% | $7.83 | 0.0% | COM | 25056L103 |
| ENGN | ENGENE HOLDINGS INC | 210,000 | $1,896 | 0.6% | $8.01 | 0.0% | COM | 29286M105 |
| ALEC | ALECTOR INC | 900,000 | $1,404 | 0.4% | $1.77 | 0.0% | COM | 014442107 |
| AMLX | AMYLYX PHARMACEUTICALS INC | 112,000 | $1,353 | 0.4% | $13.58 | 0.0% | COM | 03237H101 |
| APLS | APELLIS PHARMACEUTICALS INC | 50,000 | $1,256 | 0.4% | $23.46 | 0.0% | COM | 03753U106 |
| SUPN | SUPERNUS PHARMACEUTICALS INC | 20,000 | $994 | 0.3% | $48.62 | 0.0% | COM | 868459108 |
| EWTX | EDGEWISE THERAPEUTICS INC | 30,000 | $744 | 0.2% | $20.07 | 0.0% | COM | 28036F105 |